{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:08:38Z","timestamp":1788307718426,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.vaccine.2004.01.023","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T05:18:06Z","timestamp":1076390286000},"page":"2047-2053","source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies"],"prefix":"10.1016","volume":"22","author":[{"given":"Robert T.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9303","key":"10.1016\/j.vaccine.2004.01.023_BIB1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(02)07500-1","article-title":"Cohort studies: marching towards outcomes","volume":"359","author":"Grimes","year":"2002","journal-title":"Lancet"},{"issue":"9304","key":"10.1016\/j.vaccine.2004.01.023_BIB2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(02)07605-5","article-title":"Case-control studies: research in reverse","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2004.01.023_BIB3","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/S0264-410X(02)00147-0","article-title":"Evaluation of adverse effects of vaccines: the case-control approach","volume":"20","author":"Smeeth","year":"2002","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2004.01.023_BIB4","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0264-410X(99)00292-3","article-title":"Vaccine risks: real, perceived and unknown","volume":"17","author":"Chen","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.01.023_BIB5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/jama.267.3.392","article-title":"Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine","volume":"267","author":"Howson","year":"1992","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.vaccine.2004.01.023_BIB6","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.271.20.1602","article-title":"Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine","volume":"271","author":"Stratton","year":"1994","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2004.01.023_BIB7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The vaccine adverse event reporting system (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.023_BIB8","unstructured":"McNeill WH, Plagues and peoples. Garden City, NY: Anchor Press; 1976."},{"issue":"6","key":"10.1016\/j.vaccine.2004.01.023_BIB9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg. Infect. Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2004.01.023_BIB10","first-page":"1319","article-title":"Smallpox vaccination policy\u2014the need for dialogue","volume":"346","author":"Fauci","year":"2002","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.vaccine.2004.01.023_BIB11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/323897","article-title":"Countering the posteradication threat of smallpox and polio","volume":"34","author":"Henderson","year":"2002","journal-title":"Clin. Infect. Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2004.01.023_BIB12","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/368038","article-title":"Future savings from measles eradication in industrialized countries","volume":"187","author":"Carabin","year":"2003","journal-title":"J. Infect. Dis"},{"issue":"9310","key":"10.1016\/j.vaccine.2004.01.023_BIB13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(02)08051-0","article-title":"Anthrax vaccine is safe and effective-but needs improvement, says IOM","volume":"359","author":"Larkin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.01.023_BIB14","unstructured":"Centers for Disease Control and Prevention. Smallpox vaccine adverse events monitoring and response system for the first stage of the smallpox vaccination program. MMWR Morb Mortal Wkly Rep 2003;52(5):88\u20139, 99."},{"key":"10.1016\/j.vaccine.2004.01.023_BIB15","unstructured":"Rothman KJ, Causal inference. Chestnut Hill, MA: Epidemiology Resources, Inc.; 1988."},{"issue":"5","key":"10.1016\/j.vaccine.2004.01.023_BIB16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/pds.616","article-title":"Safety considerations for new vaccine development","volume":"10","author":"Ellenberg","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2004.01.023_BIB17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(03)00511-5","article-title":"Standardized case definitions of adverse events following immunization (AEFI)","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.023_BIB18","first-page":"1551","article-title":"Reporting vaccine-associated adverse events","volume":"43","author":"Duclos","year":"1997","journal-title":"Can. Fam. Physician"},{"issue":"8","key":"10.1016\/j.vaccine.2004.01.023_BIB19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.vaccine.2004.01.023_BIB20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200104000-00008","article-title":"Population-based study of rotavirus vaccination and intussusception","volume":"20","author":"Kramarz","year":"2001","journal-title":"Pediatr. Infect. Dis. J"},{"key":"10.1016\/j.vaccine.2004.01.023_BIB21","unstructured":"Muetsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, et al. Bell\u2019s palsy after a new intranasal influenza vaccine\u2014Switzerland, 2000\u20132001. N Engl J Med 2004, in press."},{"issue":"9307","key":"10.1016\/j.vaccine.2004.01.023_BIB22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(02)07783-8","article-title":"Autism, bowel inflammation, and measles","volume":"359","author":"Walker-Smith","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2004.01.023_BIB23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/367667","article-title":"Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?","volume":"36","author":"Skowronski","year":"2003","journal-title":"Clin. Infect. Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2004.01.023_BIB24","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1001\/jama.287.24.3245","article-title":"Content and design attributes of antivaccination web sites","volume":"287","author":"Wolfe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2004.01.023_BIB25","doi-asserted-by":"crossref","unstructured":"Zanoni G, Nguen TMD, Valsecchi M, Gallo G, Tridente G. Prevention and monitoring of vaccine adverse events following immunization: the green channel of the Veneto region in Italy. Vaccine 2004;22(2):194\u2013201.","DOI":"10.1016\/S0264-410X(03)00566-8"},{"issue":"6","key":"10.1016\/j.vaccine.2004.01.023_BIB26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1440-1754.1999.00419.x","article-title":"Vaccination of children following a previous hypotonic-hyporesponsive episode","volume":"35","author":"Goodwin","year":"1999","journal-title":"J. Paediatr. Child Health"},{"issue":"18","key":"10.1016\/j.vaccine.2004.01.023_BIB27","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.286.18.2270","article-title":"Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review","volume":"286","author":"Phillips","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2004.01.023_BIB28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1525-1497.2002.10518.x","article-title":"Evidence-based practice for mere mortals: the role of informatics and health services research","volume":"17","author":"Sim","year":"2002","journal-title":"J. Gen. Intern. Med"},{"issue":"8949","key":"10.1016\/j.vaccine.2004.01.023_BIB29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(95)90471-9","article-title":"A new method for active surveillance of adverse events from diphtheria\/tetanus\/pertussis and measles\/mumps\/rubella vaccines","volume":"345","author":"Farrington","year":"1995","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.vaccine.2004.01.023_BIB30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.vaccine.2004.01.023_BIB31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.vaccine.2004.01.023_BIB32","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jama.278.14.1176","article-title":"Hair loss after routine immunizations","volume":"278","author":"Wise","year":"1997","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2004.01.023_BIB33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/oxfordjournals.aje.a008695","article-title":"Case series analysis of adverse reactions to vaccines: a comparative evaluation","volume":"143","author":"Farrington","year":"1996","journal-title":"Am. J. Epidemiol"},{"key":"10.1016\/j.vaccine.2004.01.023_BIB34","unstructured":"Schlesselman JJ, Case-control studies: design, conduct, analysis. New York: Oxford University Press; 1982."},{"issue":"9","key":"10.1016\/j.vaccine.2004.01.023_BIB35","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1054\/bjoc.2001.2065","article-title":"Thirty-five-year mortality following receipt of","volume":"85","author":"Carroll-Pankhurst","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"6276","key":"10.1016\/j.vaccine.2004.01.023_BIB36","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/bmj.282.6276.1595","article-title":"Pertussis immunisation and serious acute neurological illness in children","volume":"282","author":"Miller","year":"1981","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"6","key":"10.1016\/j.vaccine.2004.01.023_BIB37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0264-410X(90)90003-5","article-title":"The NCES reconsidered: summary of a 1989 workshop. National Childhood Encephalopathy Study","volume":"8","author":"Marcuse","year":"1990","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.01.023_BIB38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJM200201173460317","article-title":"More on rotavirus vaccination and intussusception","volume":"346","author":"Murphy","year":"2002","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.vaccine.2004.01.023_BIB39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.99.6.765","article-title":"Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team","volume":"99","author":"Chen","year":"1997","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2004.01.023_BIB40","first-page":"186","article-title":"The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA","volume":"78","author":"Chen","year":"2000","journal-title":"Bull. World Health Org"},{"issue":"1","key":"10.1016\/j.vaccine.2004.01.023_BIB41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2458-1-2","article-title":"A case-control study of autism and mumps\u2013measles\u2013rubella vaccination using the general practice research database: design and methodology","volume":"1","author":"Smeeth","year":"2001","journal-title":"BMC Publ. Health"},{"issue":"2","key":"10.1016\/j.vaccine.2004.01.023_BIB42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/oxfordjournals.aje.a116479","article-title":"Confounding in studies of adverse reactions to vaccines","volume":"136","author":"Fine","year":"1992","journal-title":"Am. J. Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.01.023_BIB43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.613","article-title":"The Vaccine Safety Datalink project","volume":"10","author":"DeStefano","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T23:55:16Z","timestamp":1550188516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":43,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0264410X04000490"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.01.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}